A citation-based method for searching scientific literature

Tuya Pal, Jenny Permuth-Wey, Judith A Betts, Jeffrey P Krischer, James Fiorica, Hector Arango, James LaPolla, Mitchell Hoffman, Martin A Martino, Katie Wakeley, George Wilbanks, Santo Nicosia, Alan Cantor, Rebecca Sutphen. Cancer 2005
Times Cited: 491

Panagiotis A Konstantinopoulos, Raphael Ceccaldi, Geoffrey I Shapiro, Alan D D'Andrea. Cancer Discov 2015
Times Cited: 320

List of shared articles

Times cited

Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines.
Setor Amuzu, Euridice Carmona, Anne-Marie Mes-Masson, Celia M T Greenwood, Patricia N Tonin, Jiannis Ragoussis. Cancers (Basel) 2021

Prexasertib: an investigational checkpoint kinase inhibitor for the treatment of high-grade serous ovarian cancer.
Giulio Evangelisti, Fabio Barra, Melita Moioli, Paolo Sala, Sara Stigliani, Claudio Gustavino, Sergio Costantini, Simone Ferrero. Expert Opin Investig Drugs 2020

Lessons learned from understanding chemotherapy resistance in epithelial tubo-ovarian carcinoma from BRCA1and BRCA2mutation carriers.
Cécile Le Page, Setor Amuzu, Kurosh Rahimi, Walter Gotlieb, Jiannis Ragoussis, Patricia N Tonin. Semin Cancer Biol 2020

Targeting homologous repair deficiency in breast and ovarian cancers: Biological pathways, preclinical and clinical data.
Elodie Chartron, Charles Theillet, Séverine Guiu, William Jacot. Crit Rev Oncol Hematol 2019

BRCA mutation testing for ovarian cancer in the context of available targeted therapy: Survey and consensus of Hong Kong specialists.
Ava Kwong, Ka-Leung Danny Cheng, Chan-Chee Victor Hsue, Sze-Ki Hui, Ching-Yu Roland Leung, Kwong-Chuen Angus Leung, Kai-Cheong Roger Ngan, Sung Inda Soong. Asia Pac J Clin Oncol 2019

Phase I/Ib study of olaparib and carboplatin in heavily pretreated recurrent high-grade serous ovarian cancer at low genetic risk.
Erika J Lampert, John L Hays, Elise C Kohn, Christina M Annunziata, Lori Minasian, Minshu Yu, Nicolas Gordon, Tristan M Sissung, Victoria L Chiou, William D Figg,[...]. Oncotarget 2019

Constitutional Mosaic Epimutations - a hidden cause of cancer?
Per E Lønning, Hans P Eikesdal, Inger M Løes, Stian Knappskog. Cell Stress 2019

Biomarkers in ovarian cancer: To be or not to be.
Rebecca Arend, Alba Martinez, Tomasz Szul, Michael J Birrer. Cancer 2019